1. |
Adams GGW. ROP in Asia[J]. Eye (Lond), 2020, 34(4): 607-608. DOI: 10.1038/s41433-019-0620-y.
|
2. |
王亮, 张自峰, 陶梦璋, 等. 中国大陆地区2008至2018年早产儿视网膜病变发病变化趋势[J]. 中华眼科杂志, 2021, 57(5): 379-385. DOI: 10.3760/cma.j.cn112142-20200702-00445.Wang L, Zhang ZF, Tao MZ, et al. The prevalence of retinopathy of prematurity in the mainland of China from 2008 to 2018[J]. Chin J Ophthalmol, 2021, 57(5): 379-385. DOI: 10.3760/cma.j.cn112142-20200702-00445.
|
3. |
International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited[J]. Arch Ophthalmol, 2005, 123(7): 991-999. DOI: 10.1001/archopht.123.7.991.
|
4. |
中华医学会眼科学分会眼底病学组. 中国早产儿视网膜病变筛查指南(2014年)[J]. 中华眼科杂志, 2014, 50(12): 933-935. DOI: 10.3760/cma.j.issn.0412-4081.2014.12.017.Chinese Medical Association Ophthalmology Branch Fundus Study Group. Guidelines for screening retinopathy of premature infants in China (2014)[J]. Chin J Ophthalmol, 2014, 50(12): 933-935. DOI: 10.3760/cma.j.issn.0412-4081.2014.12.017.
|
5. |
Kim SJ, Port AD, Swan R, et al. Retinopathy of prematurity: a review of risk factors and their clinical significance[J]. Surv Ophthalmol, 2018, 63(5): 618-637. DOI: 10.1016/j.survophthal.2018.04.002.
|
6. |
巨晓芳, 李家宁, 律鹏, 等. 261例青海新生儿重症监护病房早产儿视网膜病变筛查及相关危险因素分析[J]. 中华眼底病杂志, 2012, 28(1): 76-78. DOI: 10.3760/cma.j.issn.1005-1015.2012.01.020.Ju XF, Li JN, Lyu P, et al. Screening and risk factors analysis of retinopathy of prematurity in 261 premature infants in Neonatal Intensive Care Units in Qinghai[J]. Chin J Ocul Fundus Dis, 2012, 28(1): 76-78. DOI: 10.3760/cma.j.issn.1005-1015.2012.01.020.
|
7. |
马学仁, 张琼, 康宏, 等. 青海省310例早产儿视网膜病变筛查结果及其危险因素分析[J]. 中华眼底病杂志, 2017, 33(6): 631-632. DOI: 10.3760/cma.j.issn.1005-1015.2017.06.018.Ma XR, Zhang Q, Kang H, et al. Screening results and risk factors analysis of retinopathy of prematurity in 310 premature infants in Qinghai[J]. Chin J Ocul Fundus Dis, 2017, 33(6): 631-632. DOI: 10.3760/cma.j.issn.1005-1015.2017.06.018.
|
8. |
Ducsay CA, Goyal R, Pearce WJ, et al. Gestational hypoxia and developmental plasticity[J]. Physiol Rev, 2018, 98(3): 1241-1334. DOI: 10.1152/physrev.00043.2017.
|
9. |
Yu CW, Popovic MM, Dhoot AS, et al. Demographic risk factors of retinopathy of prematurity: a systematic review of population-based studies[J]. Neonatology, 2022, 119(2): 151-163. DOI: 10.1159/000519635.
|
10. |
Simonson TS, Yang Y, Huff CD, et al. Genetic evidence for high-altitude adaptation in Tibet[J]. Science, 2010, 329(5987): 72-75. DOI: 10.1126/science.1189406.
|
11. |
van Patot MC, Gassmann M. Hypoxia: adapting to high altitude by mutating EPAS-1, the gene encoding HIF-2alpha[J]. High Alt Med Biol, 2011, 12(2): 157-167. DOI: 10.1089/ham.2010.1099.
|
12. |
Wang Y, Dang ZH, Gan LY, et al. The influence of altitude on erythropoietin resistance index in maintenance hemodialysis patients: data from Tibetan plateau[J]. Blood Purif, 2021, 50(3): 364-369. DOI: 10.1159/000510997.
|
13. |
Petousi N, Croft QP, Cavalleri GL, et al. Tibetans living at sea level have a hyporesponsive hypoxia-inducible factor system and blunted physiological responses to hypoxia[J]. J Appl Physiol (1985), 2014, 116(7): 893-904. DOI: 10.1152/japplphysiol.00535.2013.
|
14. |
Kim JH, Kim JH, Yu YS, et al. Deguelin inhibits retinal neovascularization by down-regulation of HIF-1alpha in oxygen-induced retinopathy[J]. J Cell Mol Med, 2008, 12(6): 2407-2415. DOI: 10.1111/j.1582-4934.2008.00243.x.
|
15. |
Hoppe G, Yoon S, Gopalan B, et al. Comparative systems pharmacology of HIF stabilization in the prevention of retinopathy of prematurity[J/OL]. Proc Natl Acad Sci USA, 2016, 113(18): E2516-2525[2016-05-03]. https://pubmed.ncbi.nlm.nih.gov/27091985/. DOI: 10.1073/pnas.1523005113.
|
16. |
Huang H, Van de Veire S, Dalal M, et al. Reduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration[J]. Invest Ophthalmol Vis Sci, 2011, 52(10): 7565-7573. DOI: 10.1167/iovs.11-8002.
|
17. |
Vij AG, Dutta R, Satija NK. Acclimatization to oxidative stress at high altitude[J]. High Alt Med Biol, 2005, 6(4): 301-310. DOI: 10.1089/ham.2005.6.301.
|
18. |
Zamudio S, Kovalenko O, Vanderlelie J, et al. Chronic hypoxia in vivo reduces placental oxidative stress[J]. Placenta, 2007, 28(8-9): 846-853. DOI: 10.1016/j.placenta.2006.11.010.
|
19. |
Tissot van Patot MC, Murray AJ, Beckey V, et al. Human placental metabolic adaptation to chronic hypoxia, high altitude: hypoxic preconditioning[J]. Am J Physiol Regul Integr Comp Physiol, 2010, 298(1): 166-172. DOI: 10.1152/ajpregu.00383.2009.
|
20. |
Graziosi A, Perrotta M, Russo D, et al. Oxidative stress markers and the retinopathy of prematurity[J/OL]. J Clin Med, 2020, 9(9): 2711[2020-08-21]. https://pubmed.ncbi.nlm.nih.gov/32825796/. DOI: 10.3390/jcm9092711.
|
21. |
Hartnett ME. Advances in understanding and management of retinopathy of prematurity[J]. Surv Ophthalmol, 2017, 62(3): 257-276. DOI: 10.1016/j.survophthal.2016.12.004.
|